−0.030CAD
−6.29 MCAD
175.75 M
About HELIX BIOPHARMA CORP
Sector
CEO
Jacek Antas
Headquarters
Toronto
Website
Employees (FY)
7
Founded
1995
ISIN
CA4229101098
FIGI
BBG000C15MR0
Helix BioPharma Corp. is an immuno-oncology company, which engages in the development of products for the treatment and prevention of cancer. It also funds research through issuance of common shares and warrants. The company was founded by Jerome F. McElroy on July 31, 1995 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of HBP is 0.20 CAD — it has decreased by 12.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange HELIX BIOPHARMA CORP stocks are traded under the ticker HBP.
HELIX BIOPHARMA CORP is going to release the next earnings report on Jun 11, 2024. Keep track of upcoming events with our Earnings Calendar.
HBP earnings for the last quarter are −0.02 CAD whereas the estimation was −0.02 CAD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.02 CAD. See more details about HELIX BIOPHARMA CORP earnings.
Yes, you can track HELIX BIOPHARMA CORP financials in yearly and quarterly reports right on TradingView.
Like other stocks, HBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HELIX BIOPHARMA CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 7.00 employees. See our rating of the largest employees — is HELIX BIOPHARMA CORP on this list?